Participants
Speakers
Sessions
Sponsors
Event Schedule
Full-day Events with Awesome Speakers
10TH AUGUST 2019, SATURDAY
Charting the CRISPR IP landscape
GBR
The CRISPR patent landscape beyond the United States: Europe, Asia and the rest of the world
The future of CRISPR patent licensing
Patentability issues surrounding gene-editing technologies
Critical issues on Pharma Patenting for ANDA and NDA applications
GBR
Common Filing Deficiencies in Abbreviated New Drug Applications (ANDA)
PARA – IV Filing & 180 days market exclusivity
Is 505(b)(2) filing a safer strategy: Avoiding a known risk?
Hatch-Waxman and BPCIA Developments
Regulatory provisions for marketing of Patented Drugs in India
GBR
Clinical Trials, access to medicines and the regulatory provisions in India
Patient Assistance Program (PAP) and differential pricing
Public Health Issues & Compulsory Licensing
GBR
- Compulsory licensing, price controls, and access to patented foreign products
- Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry
Speaker -
- Ms. Uma Baskaran, Consultant, Krishna & Saurastri Associates LLP - Compulsory licensing, price controls and access to patented foreign products
